TLR9 and Autoimmunity: Indeed, it was demonstrated in the present study that the addition of sema3A, in vitro, to B cells of SLE patients, significantly reduced ODN-CpG induced TLR-9 expression in memory B cells, supporting sema3A as a regulator of autoimmunity in SLE.